Navigation Links
Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
Date:2/9/2009

ket value inventory adjustment (g) 1.0 - Rental tax dispute (h) - 1.6 --- --- Adjusted operating income (2) $363.7 $327.1 ====== ====== GAAP operating margin 9.6% 9.9% Impact of adjustments (2) 2.1% 1.9% ---- --- Adjusted operating margin (2) 11.7% 11.8% ===== ==== (1) Amounts may not foot due to rounding. (2) See accompanying Non-GAAP Financial Measures section for description of Non-GAAP adjustments. BECKMAN COULTER, INC. RECONCILIATION OF GAAP NET EARNINGS TO ADJUSTED NET EARNINGS (1) (in millions, except amounts per share) (unaudited) Quarter Ended December 31, -------------------------- 2008 2007 -------------------- ----------------- Per Per Diluted Diluted Amount Share Amount Share ------ ------- ------ ------- GAAP net earnings $77.2 $1.21 $44.8 $0.69 Reconciling items: ----------------- Restructuring expenses (a) 8.2 0.13 4.2 0.07 NexGen acquisition (e) - - 35.4 0.55 Adjustment for income taxes
'/>"/>
SOURCE Beckman Coulter - IR
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... 5 The endangered black-footed fer... This rare carnivore feeds on prairie dogs. The...ften entire population die-offs in towns occur. T...emented a ferret breeding program and has been rel...y native habitat. Unfortunately, plague can sweep...
(Date:11/5/2009)...wswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulleti...er, President and CEO of Imagenetix, will be prese...RO Conference on Thursday, December 3rd, at 10:30 ...out LD MICRO ,, LD MICRO is a by-invitation onl...ued companies in the micro-cap space. Since 2002, ...
(Date:11/5/2009)...sday, November 5, 2009 at 4:30 p.m. Eastern Time ,...-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("On...reported unaudited financial results for the third...and reviewed the Company,s highlights for the thir...d results reflect the operations of OncoGenex Tech...
(Date:11/5/2009)... BioSpecifics Technologie...any developing first-in-class collagenase-based pr...the third quarter ended September 30, 2009. ,,...is year, the FDA,s Arthritis Advisory Committee un...oval of XIAFLEX(TM) for the treatment of Dupuytren...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...Earn Decision Resources, Clinical Gold Standard St...ew Report from Decision Resources , , WALTHAM, Ma...d,s leading research and advisory firms for pharma...d endocrinologists indicate that a therapy,s effec...tribute that most influences their prescribing dec...
... The world,s first metallic needle AFM pro.... Featuring a unique combination of high aspect, c...c needle probes are enabling new applications in n... Phoenix, AZ (PRWEB) March 24, 2009 -- ...nanotechnology instrumentation and supplies, today...
...ovide CellDesign,s proprietary adipocyte different... March 24 Stemgent has signed a co-exclusive lice... and AdipoDesign MaxiKit, which enable researchers...enitor cells. This agreement strengthens Stemgent...earch technologies and enables CellDesign to take ...
Other Biology Technology:Surveyed Experts Indicate That Byetta LAR and Victoza Have Advantages Over Actos in the Treatment of Type 2 Diabetes 2Surveyed Experts Indicate That Byetta LAR and Victoza Have Advantages Over Actos in the Treatment of Type 2 Diabetes 3Nanoscience Instruments, Inc. Announces Distribution of NaugaNeedles Metallic Needle AFM Tips 2Stemgent, CellDesign Sign Co-Exclusive Marketing Agreement on Stem Cell-Based Adipocyte Research Products 2
(Date:11/6/2009)...6, 2009) The Monell Center and the Chinese Academ...ternational Meeting on Taste and Smell Research. O...the meeting will be the first international meetin... Leshner, Chief Executive Officer, American Associ... Publisher of Science magazine, will open the meet...
(Date:11/4/2009)...atural science) , United States Using Less Wat...day than it did 35 years ago, despite a 30 percent...rtly attributable to alternative cooling methods a...ms. According to the latest USGS water use report,...s goes to cooling thermoelectric power plants. Irr...
(Date:11/4/2009)...ma at Norman has received more than $10 million in...t of the federal stimulus program, bringing thetot...rchers to $23 million. Thirty-three projects achi...haeology to weather. , "The university has thoug...ng areasof scholarly excellence to federal agency ...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR 28R 29 51761 1Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR 28R 29 51761 2Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 1Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 2Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 3Billians HealthDATA Launches New Version of Online Healthcare Database 51755 1Billians HealthDATA Launches New Version of Online Healthcare Database 51755 2
...ene silencing nanoparticles into tumor cells has b...model of the disease. , In this classic "Trojan h...normally delivers iron into cells is modified to a...ing RNA) encased in nano-sized sugar polymers. The...omoting gene called EWS-FLI1 that,s active only in...
...uman immunodeficiency virus hijacks that cell,s no... New HIV particles roll off the cellular assembly ...at off to invade other cellular factories. Vanderb...ow identified an early step in HIV particle assemb...d lead to new drugs that combat HIV infection by s...
...arch Institute is reporting a discovery that sheds...thing from the normal processes that govern the ev...sms that underlie many diseases, including cancer ...ragments of RNA known as microRNA and their relati...er RNA (mRNA). , All genes expressed in the human...
Other Biology News:Novel gene-silencing nanoparticles shown to inhibit Ewing's sarcoma 2Novel gene-silencing nanoparticles shown to inhibit Ewing's sarcoma 3Shutting down the HIV assembly line 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 3Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 4
Goat Anti-Adducin beta (C-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
GIBCO Geneticin Selective Antibiotic liquid from Invitrogen
Blot module from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-STAT Sampler Pack Antibody, Unconjugated from Invitrogen
Biology Products: